COMMUNIQUÉS West-GlobeNewswire
-
Acquisition of Ovizio Imaging Systems SA
16/10/2024 - 16:36 -
Le KFNCCC : un leader régional dans le traitement des cancers pédiatriques
16/10/2024 - 16:42 -
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
16/10/2024 - 16:45 -
Eurobio Scientific : levée de la dernière condition suspensive règlementaire au projet d’OPA initié par EB Development
16/10/2024 - 16:50 -
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
16/10/2024 - 17:00 -
Compass Health delivers mental health services at first school-based health clinic in Bellingham Public Schools
16/10/2024 - 17:00 -
Steve Aoki Joins Neuro Gum as Investor, Backing the Brand Revolutionizing Mental Performance
16/10/2024 - 17:22 -
Valneva and LimmaTech reçoivent le statut « Fast Track » de la FDA pour leur candidat vaccin tétravalent contre la Shigellose S4V
16/10/2024 - 17:45 -
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
16/10/2024 - 17:45 -
Legend Senior Living® Assumes Management of Two Senior Living Communities in Bucks County, PA
16/10/2024 - 18:04 -
Epilepsy Foundation Welcomes New Chief Financial Officer
16/10/2024 - 18:05 -
Enlitic, Inc. Welcomes Brenda Rankin as Chief Operating Officer
16/10/2024 - 18:16 -
Move Health Acquires Fountain Wellness and Enters into Medical Spa and Longevity Industry
16/10/2024 - 19:00 -
Singlera Genomics presents results of PDACatch preclinical study at HM Hospitals Annual Early Detection Meeting
16/10/2024 - 20:34 -
Sienna Senior Living Expands Into Alberta With Portfolio Acquisition
16/10/2024 - 22:05 -
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/10/2024 - 22:05 -
NeuroPace Continues to Strengthen Management Team
16/10/2024 - 22:05 -
Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024
16/10/2024 - 22:05 -
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16/10/2024 - 22:15
Pages